(Lee Biosolutions

L-NAME hydrochloride
2356-100 each
EUR 144

Human IgG antibody Laboratories manufactures the (lee biosolutions reagents distributed by Genprice. The (Lee Biosolutions reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other (Lee products are available in stock. Specificity: (Lee Category: Biosolutions

L-NAME hydrochloride
1
EUR 15.9

L-NAME hydrochloride
25
EUR 174

L-NAME hydrochloride
5
EUR 55.4

JBS True Blue
300 µl
EUR 16
Description: JBS True Blue

B / Lee / 40 Strain Protein
1 ml
EUR 1228.8

Index Name Not Yet Assigned
  • EUR 5204.40
  • EUR 1095.60
  • EUR 326.40
  • EUR 1914.00
  • EUR 710.40
  • 100 g
  • 10 g
  • 1 g
  • 25 g
  • 5 g

Human True insulin ELISA kit
192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Chemicals information

LEE011
A8641-10 10 mg
EUR 226.8
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-25 25 mg
EUR 338.4
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-5 5 mg
EUR 170.4
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-5.1 10 mM (in 1mL DMSO)
EUR 181.2
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
A8641-50 50 mg
EUR 408
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2].

LEE011
GW0606-1 1
EUR 121.8

LEE011
GW0606-10 10
EUR 237.4

LEE011
GW0606-5 5
EUR 171.5

LEE011 succinate
B1084-10 10 mg
EUR 200.4
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-100 100 mg
EUR 420
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-200 200 mg
EUR 640.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5 5 mg
EUR 160.8
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-5.1 10 mM (in 1mL DMSO)
EUR 192
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-50 50 mg
EUR 300
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

LEE011 succinate
B1084-500 500 mg
EUR 1101.6
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Biosystem Archive 40
CRY3332 EACH
EUR 56354.92

Biosystem Archive 60
CRY3334 EACH
EUR 63819.03